Lisanne P. Zijlker

Neoadjuvant nivolumab + T-VEC combination therapy for resectable early stage or metastatic (IIIB-IVM1a) melanoma with injectable disease: study protocol of the NIVEC trial

Maartje W. Rohaan, Emma H. A. Stahlie, Viola Franke et al. · BMC Cancer · 2022 · 34 citations · Full text

The end of wide local excision (WLE) margins for melanoma ?

Lisanne P. Zijlker, Alexander M.M. Eggermont, Alexander C. J. van Akkooi · European Journal of Cancer · 2022 · 19 citations · Full text

Surgical Oncology, Wide Local Excision, Medicine +8

Avelumab treatment for patients with metastatic Merkel cell carcinoma can be safely stopped after 1 year and a PET/CT–confirmed complete response

Lisanne P. Zijlker, Sonja Levy, W. Wolters et al. · Cancer · 2023 · 15 citations · Full text

Surgical outcomes of lymph node dissections for stage III melanoma after neoadjuvant systemic therapy are not inferior to upfront surgery

Lisanne P. Zijlker, Stijn J. C. van der Burg, Christian U. Blank et al. · European Journal of Cancer · 2023 · 13 citations · Full text

Lymph Node Dissections, Neoadjuvant Systemic Therapy, Surgical Oncology +9

The effect of a single dose of nivolumab prior to isolated limb perfusion for patients with in-transit melanoma metastases: An interim analysis of a phase Ib/II randomized double-blind placebo-controlled trial (NivoILP trial)

Carl Jacob Holmberg, Lisanne P. Zijlker, Dimitrios Katsarelias et al. · European Journal of Surgical Oncology · 2024 · 11 citations · Full text